CAMP Q2 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-0.80

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$786,000

Balance Sheet

Total Assets

$30M

Total Liabilities

$177M

Stockholders' Equity

-$147M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$71M	-100.0%
Gross Profit	$0	$27M	-100.0%
Operating Income	-$13M	-$3M	-404.7%
Net Income	-$13M	-$4M	-211.9%